Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.40)
# 3,526
Out of 5,174 analysts
177
Total ratings
41.33%
Success rate
-3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $3.85 | +107.79% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $118.69 | +72.72% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $86.58 | +35.14% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $86.32 | +10.06% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $471.91 | +37.74% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.01 | +33.19% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $108.92 | -12.78% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $74.24 | +14.49% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $35.70 | -57.98% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $225.50 | +52.11% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.31 | +968.70% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $16.72 | +187.08% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $81.69 | +24.86% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $68.15 | -14.89% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.71 | +27.31% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $66.60 | +96.70% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $104.06 | +27.81% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $328.51 | -33.03% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $106.56 | +254.73% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $3.85
Upside: +107.79%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $118.69
Upside: +72.72%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $86.58
Upside: +35.14%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $86.32
Upside: +10.06%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $471.91
Upside: +37.74%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.01
Upside: +33.19%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $108.92
Upside: -12.78%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $74.24
Upside: +14.49%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $35.70
Upside: -57.98%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $225.50
Upside: +52.11%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.31
Upside: +968.70%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $16.72
Upside: +187.08%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $81.69
Upside: +24.86%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $68.15
Upside: -14.89%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.71
Upside: +27.31%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $66.60
Upside: +96.70%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $104.06
Upside: +27.81%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $328.51
Upside: -33.03%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $106.56
Upside: +254.73%